510(k) Report

510(k) · Cleared

Cleared

Neuroport Neural Signal Processor (NSP) System

K042626510(k) TraditionalCleared Mar 28, 2005182-day reviewClass II21 CFR 882.1400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cyberkinetics, Inc. · GWQ Full-Montage Standard Electroencephalograph

Cleared on Mar 28, 2005 after a 182-day review. The FDA summary names its predicate without a number. 16 later devices descend from it.

Decided
Mar 28, 2005
Review
182 days
Class
Class II
Product code
GWQ
Recalls
None
Predicates
0

16 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2009: 1 descendant cleared2011: 2 descendants cleared2006: 1 descendant cleared2021: 1 descendant cleared2013: 1 descendant cleared2017: 3 descendants cleared2015: 2 descendants cleared2018: 2 descendants cleared2022: 2 descendants cleared2026: 1 descendant cleared20052010201520202025
  1. This deviceK042626 Neuroport Neural Signal Processor (NSP) SystemCyberkinetics, Inc. · 2005
  2. Descendant · cites it directly · 13 of its ownK090957 Blackrock Neuroport Biopotential Signal Processing SystemI2s Micro Implantable Systems, LLC · 2009 · Recalled
  3. Descendant · cites it directly · 9 of its ownK060523 Neuroport Neural Signal Processing SystemCyberkinetics, Inc. · 2006
  4. Descendant · 2 generations on · 7 of its ownK103140 Nicolet Wireless EegCarefusion 209, Inc. · 2011 · Recalled
  5. Descendant · 2 generations on · 3 of its ownK122196 Cervello Bio-Potential Signal Acquistion System Product FamilyBlackrock Neuromed, LLC · 2013
  6. Descendant · 3 generations on · 1 of its ownK170441 ElectroTekMobilemedtek · 2017 · Recalled

Showing 5 of 16 descendants. See all descendants

Descendants cleared per year

2006: 12009: 12011: 22013: 12015: 22017: 32018: 22021: 12022: 22026: 1
2006high 3 (2017) · low 0 (2007)2026

Most influential descendants

Showing 5 of 16 · See all
  • K090957Blackrock Neuroport Biopotential Signal Processing SystemI2s Micro Implantable Systems, LLC · 2009 · cites it directly13descendants
  • K060523Neuroport Neural Signal Processing SystemCyberkinetics, Inc. · 2006 · cites it directly9descendants
  • K103140Nicolet Wireless EegCarefusion 209, Inc. · 2011 · 2 generations on7descendants
  • K122196Cervello Bio-Potential Signal Acquistion System Product FamilyBlackrock Neuromed, LLC · 2013 · 2 generations on3descendants
  • K170441ElectroTekMobilemedtek · 2017 · 3 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K042626Neuroport Neural Signal Processor (NSP) SystemCyberkinetics, Inc.2005—
+1K090957Blackrock Neuroport Biopotential Signal Processing SystemI2s Micro Implantable Systems, LLC20092
+1K060523Neuroport Neural Signal Processing SystemCyberkinetics, Inc.2006—
+2K103140Nicolet Wireless EegCarefusion 209, Inc.20111
+2K122196Cervello Bio-Potential Signal Acquistion System Product FamilyBlackrock Neuromed, LLC2013—
+3K170441ElectroTekMobilemedtek20172

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200610
200910
201120
201310
201520
201730
201820
202110
202220
202610
FIG. 1 — Lineage of K042626, 2005–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWQ device

  1. #1 K260455 New Wave Systemscore 13.7 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—BMSI 5000 (Nicolet)
Named without a submission number
—
*—Ceegraph (Bio-Logic)
Named without a submission number
—
*—EMU 128 (XLTek)
Named without a submission number
—

What descends from it? (16)

See all 16

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K090957Blackrock Neuroport Biopotential Signal Processing SystemI2s Micro Implantable Systems, LLC200913
K060523Neuroport Neural Signal Processing SystemCyberkinetics, Inc.20069
K110967Enterprise Electrophysiology SystemNeuralynx, Inc.20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K090957 (I2s Micro Implantable Systems, LLC, 2009) has gone furthest, with 13 descendants of its own.

How does its category compare?

All GWQ devices

GWQ Full-Montage Standard Electroencephalograph: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GWQ

1in 2024

2007: 12008: 22010: 32011: 42012: 42013: 22014: 22015: 32016: 32017: 52018: 82020: 62022: 32023: 62024: 12026 (partial year): 2
2007high 8 (2018) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWQ

137in 2023

2010: 73 days median2011: 220 days median2012: 208 days median2015: 276 days median2016: 50 days median2017: 181 days median2018: 150 days median2020: 216 days median2022: 216 days median2023: 137 days median
2007high 276 (2015) · low 50 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GWQ

1in 2020

2007: 52008: 22009: 12010: 12015: 22019: 22020: 12026 (partial year): 1
2007high 5 (2007) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWQ

13in 2025

2007: 112008: 82009: 72010: 122011: 62012: 92013: 42014: 72015: 132016: 282017: 172018: 152019: 162020: 302021: 202022: 162023: 202024: 172025: 13
2007high 30 (2020) · low 4 (2013)2025

MAUDE reports naming product code GWQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—511
20082—28
20090—17
2010373112
2011422006
2012420809
20132—04
20142—07
20153276213
2016350028
20175181017
20188150015
20190—216
20206216130
20210—020
20223216016
20236137020
20241—017
20250—013
20262—1—

What is it indicated for?

The intended use of the Cyberkinetics, Inc. Neuroport Neural Signal Processor System is for temporary (<30 days) recording and monitoring of brain electrical activity.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K042626: Neuroport Neural Signal Processor (NSP) System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K042626

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026